Jamaica · Delayed Price · Currency is JMD bluebird bio Statistics
Total Valuation
JMSE:GENAC has a market cap or net worth of JMD 5.31 billion. The enterprise value is 2.91 billion.
| Market Cap | 5.31B |
| Enterprise Value | 2.91B |
Important Dates
The next estimated earnings date is Friday, August 15, 2025.
| Earnings Date | Aug 15, 2025 |
| Ex-Dividend Date | Dec 4, 2024 |
Share Statistics
JMSE:GENAC has 1.03 billion shares outstanding. The number of shares has decreased by -4.83% in one year.
| Current Share Class | 1.03B |
| Shares Outstanding | 1.03B |
| Shares Change (YoY) | -4.83% |
| Shares Change (QoQ) | -5.15% |
| Owned by Insiders (%) | 3.47% |
| Owned by Institutions (%) | 5.95% |
| Float | 165.39M |
Valuation Ratios
The trailing PE ratio is 15.79.
| PE Ratio | 15.79 |
| Forward PE | n/a |
| PS Ratio | 0.43 |
| PB Ratio | 1.22 |
| P/TBV Ratio | 1.40 |
| P/FCF Ratio | 4.14 |
| P/OCF Ratio | 3.81 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.12, with an EV/FCF ratio of 2.27.
| EV / Earnings | 8.83 |
| EV / Sales | 0.24 |
| EV / EBITDA | 5.12 |
| EV / EBIT | 7.28 |
| EV / FCF | 2.27 |
Financial Position
The company has a current ratio of 6.19, with a Debt / Equity ratio of 0.05.
| Current Ratio | 6.19 |
| Quick Ratio | 3.54 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.36 |
| Debt / FCF | 0.16 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 8.04% and return on invested capital (ROIC) is 5.57%.
| Return on Equity (ROE) | 8.04% |
| Return on Assets (ROA) | 1.90% |
| Return on Invested Capital (ROIC) | 5.57% |
| Return on Capital Employed (ROCE) | 3.08% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.93 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, JMSE:GENAC has paid 55.31 million in taxes.
| Income Tax | 55.31M |
| Effective Tax Rate | 13.89% |
Stock Price Statistics
The stock price has decreased by -27.46% in the last 52 weeks. The beta is 0.03, so JMSE:GENAC's price volatility has been lower than the market average.
| Beta (5Y) | 0.03 |
| 52-Week Price Change | -27.46% |
| 50-Day Moving Average | 5.20 |
| 200-Day Moving Average | 5.85 |
| Relative Strength Index (RSI) | 47.10 |
| Average Volume (20 Days) | 6,164 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, JMSE:GENAC had revenue of JMD 12.24 billion and earned 329.75 million in profits. Earnings per share was 0.33.
| Revenue | 12.24B |
| Gross Profit | 590.91M |
| Operating Income | 399.72M |
| Pretax Income | 398.28M |
| Net Income | 329.75M |
| EBITDA | 498.41M |
| EBIT | 399.72M |
| Earnings Per Share (EPS) | 0.33 |
Balance Sheet
The company has 3.00 billion in cash and 202.43 million in debt, giving a net cash position of 2.80 billion or 2.71 per share.
| Cash & Cash Equivalents | 3.00B |
| Total Debt | 202.43M |
| Net Cash | 2.80B |
| Net Cash Per Share | 2.71 |
| Equity (Book Value) | 4.35B |
| Book Value Per Share | 3.84 |
| Working Capital | 7.27B |
Cash Flow
In the last 12 months, operating cash flow was 1.39 billion and capital expenditures -109.81 million, giving a free cash flow of 1.28 billion.
| Operating Cash Flow | 1.39B |
| Capital Expenditures | -109.81M |
| Free Cash Flow | 1.28B |
| FCF Per Share | 1.25 |
Margins
Gross margin is 4.83%, with operating and profit margins of 3.27% and 2.69%.
| Gross Margin | 4.83% |
| Operating Margin | 3.27% |
| Pretax Margin | 3.25% |
| Profit Margin | 2.69% |
| EBITDA Margin | 4.07% |
| EBIT Margin | 3.27% |
| FCF Margin | 10.49% |
Dividends & Yields
This stock pays an annual dividend of 0.22, which amounts to a dividend yield of 4.24%.
| Dividend Per Share | 0.22 |
| Dividend Yield | 4.24% |
| Dividend Growth (YoY) | 11.10% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 68.23% |
| Buyback Yield | 4.83% |
| Shareholder Yield | 9.07% |
| Earnings Yield | 6.21% |
| FCF Yield | 24.18% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |